Macquarie Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,680
Closed -$18.3K 1731
2024
Q2
$18.3K Buy
+2,680
New +$11.5K ﹤0.01% 1635
2022
Q4
Sell
-465
Closed -$22K 1862
2022
Q3
$22K Sell
465
-562
-55% -$15.6K ﹤0.01% 2163
2022
Q2
$32K Hold
1,027
﹤0.01% 2171
2022
Q1
$42 Hold
1,027
﹤0.01% 2196
2021
Q4
$45K Sell
1,027
-25,495
-96% -$1.15M ﹤0.01% 2187
2021
Q3
$1.33M Hold
26,522
﹤0.01% 1512
2021
Q2
$1.67M Buy
26,522
+1,901
+8% +$122K ﹤0.01% 1469
2021
Q1
$2.29M Buy
24,621
+2,798
+13% +$287K ﹤0.01% 1158
2020
Q4
$1.96M Buy
21,823
+2,328
+12% +$214K ﹤0.01% 1108
2020
Q3
$2.01M Sell
19,495
-7,684
-28% -$828K ﹤0.01% 1034
2020
Q2
$2.15M Sell
27,179
-983
-3% -$73.3K ﹤0.01% 991
2020
Q1
$1.63M Sell
28,162
-4,229
-13% -$244K ﹤0.01% 970
2019
Q4
$1.75M Buy
32,391
+2,856
+10% +$155K ﹤0.01% 1077
2019
Q3
$1.54M Sell
29,535
-1,359
-4% -$63.3K ﹤0.01% 1096
2019
Q2
$1.49M Buy
30,894
+3,608
+13% +$173K ﹤0.01% 1103
2019
Q1
$1.38M Buy
27,286
+3,600
+15% +$212K ﹤0.01% 1096
2018
Q4
$1.4M Sell
23,686
-3,072
-11% -$198K ﹤0.01% 1058
2018
Q3
$1.76M Sell
26,758
-4,699
-15% -$274K ﹤0.01% 1038
2018
Q2
$1.59M Buy
31,457
+1,297
+4% +$67.6K ﹤0.01% 1059
2018
Q1
$1.59M Sell
30,160
-8,867
-23% -$442K ﹤0.01% 1062
2017
Q4
$1.81M Sell
39,027
-2,546
-6% -$107K ﹤0.01% 1054
2017
Q3
$1.68M Buy
41,573
+15,604
+60% +$565K ﹤0.01% 1038
2017
Q2
$881K Buy
25,969
+197
+0.8% +$6.08K ﹤0.01% 1198
2017
Q1
$748K Sell
25,772
-728
-3% -$22.2K ﹤0.01% 1241
2016
Q4
$870K Buy
+26,500
New +$794K ﹤0.01% 1194

Other funds holding EBS